Drug Shortage Report for PMS-BETAHISTINE
Report ID | 170281 |
Drug Identification Number | 02330237 |
Brand name | PMS-BETAHISTINE |
Common or Proper name | BETAHISTINE |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | BETAHISTINE HYDROCHLORIDE |
Strength(s) | 24MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | BLISTER 4X25 |
ATC code | N07CA |
ATC description | ANTIVERTIGO PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-10-03 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-11-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-11-25 | French | Compare |
v5 | 2022-11-25 | English | Compare |
v4 | 2022-11-25 | English | Compare |
v3 | 2022-10-04 | English | Compare |
v2 | 2022-09-27 | French | Compare |
v1 | 2022-09-27 | English | Compare |
Showing 1 to 6 of 6